These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1876590)

  • 1. [Immunohistochemical markers in lung tumors--a status evaluation].
    Müller KM; Herberg U
    Pneumologie; 1991 Apr; 45(4):140-6. PubMed ID: 1876590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistological investigations of carcinoembryonic antigen (CEA) in urothelial carcinomas.
    Feil G; Wechsel HW; Nelde HJ; Bichler KH
    Anticancer Res; 1999; 19(4A):2591-7. PubMed ID: 10470200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary blastoma. Immunohistochemical characterization of heteromorphic tumor components].
    Brockmann M; Hecker A; Müller KM
    Pneumologie; 1990 Feb; 44 Suppl 1():605-6. PubMed ID: 2195530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trophoblastic markers and CEA in non-small cell lung cancer: the comparison studies of tumour cells expression and serum concentration.
    Słodkowska J; Szturmowicz M; Giedronowicz D; Rudzinski P; Sakowicz A; Kupis W
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():190-8. PubMed ID: 9337537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.
    Mimura T; Ito A; Sakuma T; Ohbayashi C; Yoshimura M; Tsubota N; Okita Y; Okada M
    Cancer; 2007 Mar; 109(5):933-8. PubMed ID: 17279584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistologic diagnosis of multiple carcinomas. The role of monoclonal antibodies against carcinoembryonic antigen.
    Guiot MC; Sawka R; Meakins JL; Jothy S
    Can J Surg; 1989 Jul; 32(4):279-82. PubMed ID: 2736454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung.
    Huang CI; Taki T; Higashiyama M; Kohno N; Miyake M
    Br J Cancer; 2000 Jan; 82(2):374-80. PubMed ID: 10646891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics.
    Mori M; Tezuka F; Chiba R; Funae Y; Watanabe M; Nukiwa T; Takahashi T
    Cancer; 1996 Feb; 77(4):665-74. PubMed ID: 8616758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
    Demarchi LM; Reis MM; Palomino SA; Farhat C; Takagaki TY; Beyruti R; Saldiva PH; Capelozzi VL
    Mod Pathol; 2000 May; 13(5):511-20. PubMed ID: 10824922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
    Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E
    Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.
    Chen Y; Knösel T; Kristiansen G; Pietas A; Garber ME; Matsuhashi S; Ozaki I; Petersen I
    J Pathol; 2003 Aug; 200(5):640-6. PubMed ID: 12898601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of morphology and tumour marker production in human epidermoid lung carcinoma xenografts.
    Bak M; Mattern J; Volm M
    In Vivo; 1987; 1(5):319-26. PubMed ID: 2485134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the tissue localization of carcinoembryonic antigen in tumors of the colonic mucosa].
    Markova E; Kamenova M
    Eksp Med Morfol; 1989; 28(4):12-6. PubMed ID: 2627895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions.
    Wu GP; Zhang SS; Fang CQ; Liu SL; Wang EH
    Cytopathology; 2008 Aug; 19(4):212-7. PubMed ID: 18699986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
    Berezowski K; Stastny JF; Kornstein MJ
    Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leu-M1, CEA and intermediate filament proteins in histochemical differential diagnosis of malignant pleural mesothelioma].
    Heckmayr M; Gatzmeier U; Schröder S; Niendorf A; Fasske E
    Pneumologie; 1990 Feb; 44 Suppl 1():618-9. PubMed ID: 2195531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
    Kobashi Y; Matsushima T; Irei T
    Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.